HEPATITIS A VIRUS (HAV) - ANVISA Registration 80146501203

Access comprehensive regulatory information for HEPATITIS A VIRUS (HAV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146501203 and manufactured by ABBOTT GMBH. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Jan 11, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146501203
2 Related Devices
Registration Details
ANVISA Registration Number: 80146501203
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

ARCHITECT HAVAB IgG CONTROLS / ARCHITECT HAVAB IgG CONTROLES
Risk Class III

Registration Details

80146501203

25351187408200460

56998701000116

Company Information

ABBOTT GMBH
Germany
PT: ALEMANHA

Dates and Status

Jan 11, 2005

11/01/2035

09/18/2025 19:00:01

ARCHITECT HAVAB IgG CONTROLS / ARCHITECT HAVAB IgG CONTROLES
Risk Class III

Registration Details

80146501203

25351187408200460

56998701000116

Company Information

Dates and Status

Jan 11, 2005

11/01/2035

09/18/2025 19:00:01